female sexual arousal, women's viagra, hormone therapy, menopause

ABOUT 25% OF WOMEN EXPERIENCE FEMALE SEXUAL AROUSAL DISORDER

Female Sexual Arousal Disorder (FSAD) affects up to 25 percent of all American women, or an estimated 47 million women who describe their sexual dysfunction as being "unable to get turned on" or being continually uninterested in sex. Symptoms include lack of "excitement," vaginal dryness, loss of sensation and sensitivity in the genitals and nipples, and low blood flow to the genitals. Three-fourths of women with FSAD are postmenopausal. Hormonal change and selective serotonin reuptake inhibitor (SSRI) anti-depressants are known sources of FSAD.

CLINICAL STUDIES SUCESS WITH SILDENAFIL

 

Recent studies support the use of sildenafil to treat women with a primary complaint of sexual arousal disorder,
says Marla Ahlgrimm, R.Ph., founder of Women’s Health America.
Individually compounded sublingual tablets or topicals offer the potential benefits of lower dosage along with decreased side effects.

 

There are numerous combinations of ingredients that have been prescribed by physicians to help women suffering from anorgasmia or reduced sensation. These may be applied topically and/ or intra-vaginally.

Please contact Compounding Docs Pharmacy to discuss your options.